| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 36.582 | 39.314 | 41.245 | 48.067 | 60.606 | 65.615 | 74.699 | 83.487 | 103.050 | 118.802 |
| Total Income - EUR | 37.996 | 39.373 | 41.885 | 48.072 | 60.617 | 65.618 | 74.702 | 83.508 | 103.063 | 123.182 |
| Total Expenses - EUR | 26.278 | 26.301 | 28.614 | 25.396 | 24.802 | 34.297 | 31.401 | 34.446 | 38.660 | 50.576 |
| Gross Profit/Loss - EUR | 11.718 | 13.072 | 13.271 | 22.676 | 35.815 | 31.321 | 43.301 | 49.061 | 64.403 | 72.607 |
| Net Profit/Loss - EUR | 10.578 | 12.679 | 12.858 | 22.196 | 35.243 | 30.755 | 42.614 | 48.349 | 63.518 | 69.318 |
| Employees | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Diplo - Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 23.437 | 20.556 | 17.873 | 15.687 | 15.311 | 18.050 | 17.086 | 16.587 | 16.147 | 15.744 |
| Current Assets | 23.665 | 22.249 | 27.191 | 38.063 | 55.655 | 63.255 | 83.433 | 102.041 | 130.157 | 173.870 |
| Inventories | 0 | 713 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 15.635 | 9.217 | 9.318 | 9.648 | 10.309 | 13.720 | 12.404 | 12.553 | 20.944 | 5.153 |
| Cash | 8.030 | 12.320 | 17.874 | 28.416 | 45.346 | 49.534 | 71.029 | 89.488 | 109.213 | 60.183 |
| Shareholders Funds | 37.495 | 39.321 | 39.255 | 50.845 | 64.030 | 59.046 | 72.049 | 78.038 | 94.822 | 103.300 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 9.607 | 3.484 | 5.809 | 2.905 | 6.936 | 22.259 | 28.469 | 40.590 | 51.482 | 86.314 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Diplo - Med Srl